TIDMTSTL

RNS Number : 6547B

Tristel PLC

05 June 2023

Tristel plc

("Tristel" or the "Company")

Analyst and Investor presentation

Re. news of FDA De Novo approval for Tristel ULT as a high level disinfectant

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the Company will hold a presentation for analysts and investors following this morning's announcement that Tristel ULT was approved by the FDA as a high level disinfectant for use on endocavity ultrasound probes and skin surface transducers.

Paul Swinney , CEO, and Liz Dixon, CFO, will provide details of the Company's North America Commercial Strategy in a presentation which is open to all existing and potential shareholders, as well as analysts.

The live presentation will take place on the Investor Meet Company platform at 4.30pm today, Monday 5 June 2023, and a replay facility will also be available shortly afterwards. Questions can be submitted at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Tristel plc to register for the presentation via: https://www.investormeetcompany.com/tristel-plc/register-investor

For further information please contact:

 
 Tristel plc                                                         Tel: 01638 721 500 
 Paul Swinney, Chief Executive 
  Officer 
 Liz Dixon, Chief Financial 
  Officer 
 
 Walbrook PR Ltd                           Tel: 020 7933 8780 or tristel@walbrookpr.com 
 Paul McManus                                                        Mob: 07980 541 893 
 Lianne Applegarth                                                   Mob: 07584 391 303 
 
 finnCap                                                             Tel: 020 7220 0500 
 Geoff Nash/ Charles Beeson (Corporate 
  Finance) 
 A lice Lane (ECM)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFIFETRTIEIIV

(END) Dow Jones Newswires

June 05, 2023 05:00 ET (09:00 GMT)

Tristel (LSE:TSTL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Tristel.
Tristel (LSE:TSTL)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Tristel.